Literature DB >> 7928466

Enhanced expression of thymidine kinase in human cells following ionizing radiation.

D A Boothman1, T W Davis, W M Sahijdak.   

Abstract

PURPOSE: We investigated the induction of thymidine kinase transcription and enzymatic activity, and the activation of transcription factors binding to the thymidine kinase promoter, in human normal compared to tumor cells in culture before and after ionizing radiation. METHODS AND MATERIALS: Northern blot, dot-blot, and thymidine kinase enzyme assays were used to observe thymidine kinase transcript and enzymatic changes before and after radiation. Temporal expression of thymidine kinase transcripts following an optimal induction dose of radiation was also studied. Gel mobility shift assays were performed using a 95-base pair fragment of the thymidine kinase promoter (containing the CCAAT box) to analyze transcription factor binding.
RESULTS: Thymidine kinase transcript and enzymatic levels were higher in human tumor compared to normal cells. In contrast, levels of x-ray-activated thymidine kinase transcription factors were not significantly different in human neoplastic compared to normal cells.
CONCLUSIONS: Elevated x-ray-induced thymidine kinase transcripts, enzymatic levels, and transcription factors are consistent with the loss of stringent cell growth regulation associated with neoplastic cells. The induction of thymidine kinase following ionizing radiation may be exploited in chemotherapeutic strategies which use halogenated pyrimidines and/or in various gene therapy strategies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7928466     DOI: 10.1016/0360-3016(94)90019-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies.

Authors:  Charles A Kunos; Tomas Radivoyevitch
Journal:  Gynecol Obstet (Sunnyvale)       Date:  2011-12-10

Review 2.  Imaging radiation response in tumor and normal tissue.

Authors:  Marjan Rafat; Rehan Ali; Edward E Graves
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

Review 3.  [18F]FLT-PET in oncology: current status and opportunities.

Authors:  Lukas B Been; Albert J H Suurmeijer; David C P Cobben; Pieter L Jager; Harald J Hoekstra; Philip H Elsinga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12       Impact factor: 9.236

4.  Deoxynucleoside salvage facilitates DNA repair during ribonucleotide reductase blockade in human cervical cancers.

Authors:  Charles A Kunos; Gina Ferris; Natalie Pyatka; John Pink; Tomas Radivoyevitch
Journal:  Radiat Res       Date:  2011-07-14       Impact factor: 2.841

5.  FLT-PET imaging of radiation responses in murine tumors.

Authors:  M H Pan; S C Huang; Y P Liao; D Schaue; C C Wang; D B Stout; J R Barrio; W H McBride
Journal:  Mol Imaging Biol       Date:  2008-08-01       Impact factor: 3.488

6.  A pilot study of the value of 18F-fluoro-deoxy-thymidine PET/CT in predicting viable lymphoma in residual 18F-FDG avid masses after completion of therapy.

Authors:  Esther Mena; Maria Liza Lindenberg; Baris I Turkbey; Joanna Shih; Jean Logan; Stephen Adler; Karen Wong; Wyndham Wilson; Peter L Choyke; Karen A Kurdziel
Journal:  Clin Nucl Med       Date:  2014-10       Impact factor: 7.794

7.  18F-FLT and 18F-FDG PET-CT imaging in the evaluation of early therapeutic effects of chemotherapy on Walker 256 tumor-bearing rats.

Authors:  Weina Xu; Shupeng Yu; Jun Xin; Qiyong Guo
Journal:  Exp Ther Med       Date:  2016-11-03       Impact factor: 2.447

8.  Regulation and functional contribution of thymidine kinase 1 in repair of DNA damage.

Authors:  Yen-Ling Chen; Staffan Eriksson; Zee-Fen Chang
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

Review 9.  Clinical trials with retrovirus mediated gene therapy--what have we learned?

Authors:  Nikolai G Rainov; Huan Ren
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

10.  Utility of 3'-[(18)F]fluoro-3'-deoxythymidine as a PET tracer to monitor response to gene therapy in a xenograft model of head and neck carcinoma.

Authors:  Neale S Mason; Brian J Lopresti; James Ruszkiewicz; Xinxin Dong; Sonali Joyce; George Leef; Malabika Sen; Abdus S Wahed; Chester A Mathis; Jennifer R Grandis; Sufi M Thomas
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.